Twist Bioscience: Strong Performance In A Soft Market

Yuichiro Chino/Moment via Getty Images Twist Bioscience (NASDAQ:TWST) recently reported strong results in Q1 FY2024, particularly given how tepid the demand environment is. While some of this strength is a mirage created by lumpy NGS revenue, Twist's business continues to scale and progress towards cash flow breakeven. The stock may not look particularly cheap given its rise over the past 3 months, but it should be kept in mind that both the Biopharma and Data Storage businesses have significant potenti ...